心臓の老化における循環抗老化 αKlotho の役割
1Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Cell signaling
|September 2, 2025
まとめ
アンチエイジングホルモンのα-Klothoは,老いたマウスの心臓機能を改善し,心臓の損傷を軽減します. これは,Klotho- Sirtuin1経路が,年齢関連の心不全の潜在的な治療標的であることを強調しています.
科学分野:
- 心臓病科
- ゲロントロジー
- 分子生物学
背景:
- 老化により心臓機能が著しく低下し,心臓不全の罹患率が増加し,特に老人における心不全のエジェクション分数保存 (HFpEF) が増加する.
- HFpEFは高齢者の罹病率と死亡率の主な原因であり,新しい治療戦略が必要である.
- 抗老化ホルモンのα-Klothoが心臓の健康に果たす役割は,新しい研究分野です.
研究 の 目的:
- 年齢に関係する心臓の腹動機能障害の改善における溶解性Klotho (sKL) の治療の可能性を調査する.
- Sirtuin1 (Sirt1) 経路に焦点を当てて,sKLの心臓保護効果の基礎にある分子メカニズムを解明する.
- 年老いた心臓の心臓構造と血管形成にSKLの影響を評価する.
主な方法:
- 老化とクロトー欠乏症のマウスモデルを用いて,老化が心臓機能に与える影響を研究した.
- 老いたマウスモデルに溶性Klotho (sKL) を投与した.
- 心臓のダイアストリック機能,左心房の縮,繊維症,毛細血管の密度が評価されました.
- DNA損傷とタンパク質アセチル化に対するsKLの作用を媒介するSirtuin1 (Sirt1) の役割を調査した.
主要な成果:
- 老いたマウスでは,溶解性Klotho (sKL) の補充により,心臓のダイアストリック機能が著しく改善されました.
- sKL治療は左心房の大幅縮小と心臓線維症を減少させた.
- sKLの投与により,老いた心臓の毛細血管の密度が増加しました.
- sKLの心臓保護効果は,Sirt1媒介によるDNA損傷経路の調節と心臓タンパク質アセチル化に依存していた.
結論:
- Klotho- Sirtuin1軸を標的とした治療は,保存されたエジェクション分数 (HFpEF) を用いて,年齢関連の腹動機能障害と心不全の治療に有望である.
- 溶解性Klotho (sKL) は,心動脈機能の改善と心臓の改造により,高齢の心臓に重要な心臓保護効果を示しています.
- これらの発見は 老化に関連した心臓血管疾患の管理に 新たな洞察をもたらします
関連する概念動画
01:26Aging
179
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
179
01:19The Effect of Aging on Tissues
2.4K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.4K
01:17Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
01:29Pathophysiology of Cardiac Performance
799
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
799
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505